MindWalk Holdings (HYFT) Enterprise Value (2020 - 2026)
MindWalk Holdings (HYFT) posted quarterly Enterprise Value of -$8.4 million for Q2 2026, down 10.29% year-over-year from -$9.3 million in Q2 2025, and up 17.45% quarter-over-quarter from -$10.1 million in Q1 2026.
MindWalk Holdings (HYFT) Enterprise Value (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Enterprise Value for 7 consecutive years, with -$8.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Enterprise Value fell 10.29% year-over-year to -$8.4 million; the TTM figure through Apr 2026 stood at -$8.4 million (down 10.29% YoY), while the FY2026 annual figure was -$8.4 million, down 7.96% from the prior year.
- Enterprise Value rose to -$8.4 million in Q2 2026 per HYFT's latest filing, from -$10.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$2.6 million in Q2 2024 and bottomed at -$26.1 million in Q1 2022.
- Historically, Enterprise Value has averaged -$9.1 million across 5 years, with a median of -$8.0 million in 2026.
- Annual changes were most pronounced in 2023 — Enterprise Value jumped 73.94% — and 2025, when it plunged 348.79%.
- MindWalk Holdings' Enterprise Value stood at -$11.3 million in 2022, then soared by 60.3% to -$4.5 million in 2023, then surged by 41.1% to -$2.7 million in 2024, then tumbled by 348.79% to -$11.9 million in 2025, then climbed by 29.66% to -$8.4 million in 2026.
- Business Quant data shows HYFT's Enterprise Value at -$8.4 million in Q2 2026, -$10.1 million in Q1 2026, and -$11.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -3.15 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -8.37 Mn |
| Jan 31, 2026 | -10.14 Mn |
| Oct 31, 2025 | -11.90 Mn |
| Jul 31, 2025 | -3.56 Mn |
| Apr 30, 2025 | -7.59 Mn |
| Jan 31, 2025 | -9.16 Mn |
| Oct 31, 2024 | -2.65 Mn |
| Jul 31, 2024 | -2.92 Mn |
| Apr 30, 2024 | -2.61 Mn |
| Jan 31, 2024 | -4.65 Mn |
| Oct 31, 2023 | -4.50 Mn |
| Jul 31, 2023 | -5.10 Mn |
| Apr 30, 2023 | -6.18 Mn |
| Jan 31, 2023 | -8.46 Mn |
| Oct 31, 2022 | -11.34 Mn |
| Jul 31, 2022 | -14.96 Mn |
| Apr 30, 2022 | -23.72 Mn |
| Jan 31, 2022 | -26.06 Mn |
| Oct 31, 2021 | -30.51 Mn |
| Jul 31, 2021 | -33.13 Mn |